Cite
MLA Citation
Mark E Arnold. “An industry perspective on the US FDA biomarker qualification effort.” Bioanalysis, vol. 10, 2018, pp. 913–916. http://access.bl.uk/ark:/81055/vdc_100120166516.0x00000e
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mark E Arnold. “An industry perspective on the US FDA biomarker qualification effort.” Bioanalysis, vol. 10, 2018, pp. 913–916. http://access.bl.uk/ark:/81055/vdc_100120166516.0x00000e